111604-99-0

Basic information

• Product Name: Propanedioic acid, [1-(4-methoxyphenyl)-2-[2-nitro-6-(trifluoromethyl)phenyl]ethyl]-, dimethyl ester
• CAS NO: 111604-99-0
• Molecular Formula: C21H20F3NO7
• Molecular Weight: 455.388
• Mol File: 111604-99-0.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Propanedioic acid, [1-(4-methoxyphenyl)-2-[2-nitro-6-(trifluoromethyl)phenyl]ethyl]-, dimethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Propanedioic acid, [1-(4-methoxyphenyl)-2-[2-nitro-6-(trifluoromethyl)phenyl]ethyl]-, dimethyl ester(111604-99-0)
• EPA Substance Registry System: Propanedioic acid, [1-(4-methoxyphenyl)-2-[2-nitro-6-(trifluoromethyl)phenyl]ethyl]-, dimethyl ester(111604-99-0)

Safety Data

• Hazardous Substances Data: 111604-99-0(Hazardous Substances Data)

Upstream product

• 6656-49-1 2-methyl-1-nitro-3-(trifluoromethyl)benzene 
• 7443-25-6 dimethyl 2-(4-methoxybenzylidene)malonate 
• 60-29-7 diethyl ether 
• 160693-23-2 2-(4-methoxyphenyl)-1,3-dioxane-4,6-dione 

Downstream Products

• 111605-00-6 α-(2-Propenyl)-[2-(2-nitro-6-trifluoromethylphenyl)-1-(4-methoxyphenyl)ethyl]propanedioic acid, dimethyl ester 
• 138573-31-6 2-[1-(4-Methoxy-phenyl)-2-(2-nitro-6-trifluoromethyl-phenyl)-ethyl]-2-propyl-malonic acid dimethyl ester 
• 111605-04-0 1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-propyl-6-(trifluoromethyl)-2H-1-benzazepin-2-one 
• 138573-57-6 (3S,4R)-4-(4-Methoxy-phenyl)-2-oxo-3-propyl-6-trifluoromethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine-3-carboxylic acid methyl ester 
• 111605-19-7 trans-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-methyl-6-(trifluoromethyl)-2H-1-benzazepin-2-one 
• 111605-03-9 3-Allyl-4-(4-methoxy-phenyl)-6-trifluoromethyl-1,3,4,5-tetrahydro-benzo[b]azepin-2-one 
• 111605-07-3 3-carboxy-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-6-(trifluoromethyl)-2H-1-benzazepin-2-one 
• 111605-18-6 (3S,4R)-4-(4-Methoxy-phenyl)-3-methyl-2-oxo-6-trifluoromethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine-3-carboxylic acid methyl ester 
• 111605-02-8 (3S,4R)-3-Allyl-4-(4-methoxy-phenyl)-2-oxo-6-trifluoromethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine-3-carboxylic acid methyl ester 
• 111604-76-3 trans-1-<2-(dimethylamino)ethyl>-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-methyl-6-(trifluoromethyl)-2H-1-benzazepin-2-one 
• 111604-72-9 (3R,4S)-3-Allyl-1-(2-dimethylamino-ethyl)-4-(4-methoxy-phenyl)-6-trifluoromethyl-1,3,4,5-tetrahydro-benzo[b]azepin-2-one 
• 111604-73-0 (3R,4S)-1-(2-Dimethylamino-ethyl)-4-(4-methoxy-phenyl)-3-propyl-6-trifluoromethyl-1,3,4,5-tetrahydro-benzo[b]azepin-2-one 
• 138383-13-8 (3S,4S)-3-Benzyl-1-(2-dimethylamino-ethyl)-4-(4-methoxy-phenyl)-6-trifluoromethyl-1,3,4,5-tetrahydro-benzo[b]azepin-2-one 
• 119217-19-5 (3S,4S)-1-(2-Diisopropylamino-ethyl)-4-(4-methoxy-phenyl)-3-methyl-6-trifluoromethyl-1,3,4,5-tetrahydro-benzo[b]azepin-2-one 

Relevant articles and documents

Fluoride-catalyzed Michael addition of nitrotoluenes to activated α, β-unsaturated esters

We have found that in the presence of fluoride ion, nitrotoluenes of type 1 undergo Michael addition to activated α, β-unsaturated esters of type 2 in good to excellent yield (Scheme 1). The generality and limitation of this reaction and its application t

Benzazepinone calcium channel blockers. 2. Structure-activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones

As part of a program to discover potent antihypertensive analogues of diltiazem (3a), we prepared 1-benzazepin-2-ones (4). Benzazepinones competitively displace radiolabeled diltiazem, and show the same absolute stereochemical preferences at the calcium channel receptor protein. Derivatives of 4 containing a trifluoromethyl substituent in the fused aromatic ring show potent and long-acting antihypertensive activity. Studies of the metabolism of 4 lead to the metabolically stable antihypertensive calcium channel blockers 5a and 5c. Benzazepinone 5a is a longer acting and more potent antihypertensive agent than the second generation diltiazem analogue TA-3090 (3e).

Process for benzazepine intermediates

A process is disclosed for providing benzazepine intermediates of the formulae STR1 wherein R3, R4 and Y are as defined herein, which intermediates are useful in a process for the preparation of pharmaceutically useful benzazepine de